Anika Therapeutics | ANIK - Umsatzerlöse





Der Umsatz Veränderung Datum
Abbott USD 12.59B 1.43B 2026-06
Agenus USD 33.7M 500K 2026-03
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 75.23M 1.49M 2026-06
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Halozyme Therapeutics USD 481M 104M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 425.49M 119.53M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
Intrexon USD 717K 511K 2024-06
J&J USD 25.31B 1.21B 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
MacroGenics USD 20.8M 20.43M 2026-03
Merit Medical Systems USD 418.8M 36.9M 2026-06
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.95B 710M 2026-06
Smith & Nephew USD 1.6B 1.58B 2026-06
Stryker USD 6.6B 600M 2026-06
Veracyte USD 150.32M 11.25M 2026-06
Xencor USD 51.22M 46.71M 2026-06
Zimmer Biomet Holdings USD 2.18B 90M 2026-06